Overview

Optimizing Pharmacotherapy for Bipolar Alcoholics

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the efficacy of naltrexone and valproate in the treatment of comorbid bipolar disorder and alcohol dependence.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Miami
Treatments:
Naltrexone
Valproic Acid